ATE431749T1 - Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff - Google Patents

Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff

Info

Publication number
ATE431749T1
ATE431749T1 AT03709792T AT03709792T ATE431749T1 AT E431749 T1 ATE431749 T1 AT E431749T1 AT 03709792 T AT03709792 T AT 03709792T AT 03709792 T AT03709792 T AT 03709792T AT E431749 T1 ATE431749 T1 AT E431749T1
Authority
AT
Austria
Prior art keywords
drug
cyclofructan
carrier
composition containing
topical composition
Prior art date
Application number
AT03709792T
Other languages
English (en)
Inventor
Gyoergy Lajos Kis
Christian Schoch
Dieter Lohmann
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0229019A external-priority patent/GB0229019D0/en
Priority claimed from GB0230033A external-priority patent/GB0230033D0/en
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE431749T1 publication Critical patent/ATE431749T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03709792T 2002-03-18 2003-03-17 Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff ATE431749T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP02006085 2002-03-18
GB0229019A GB0229019D0 (en) 2002-12-12 2002-12-12 Organic compounds
GB0230033A GB0230033D0 (en) 2002-12-23 2002-12-23 Organic compounds
PCT/EP2003/002760 WO2003077952A1 (en) 2002-03-18 2003-03-17 Topical composition comprising a cyclofructan, a carrier and a drug

Publications (1)

Publication Number Publication Date
ATE431749T1 true ATE431749T1 (de) 2009-06-15

Family

ID=28045916

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03709792T ATE431749T1 (de) 2002-03-18 2003-03-17 Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff

Country Status (12)

Country Link
US (2) US20060216328A1 (de)
EP (1) EP1487498B1 (de)
JP (1) JP4523287B2 (de)
CN (1) CN1313155C (de)
AT (1) ATE431749T1 (de)
AU (1) AU2003214133A1 (de)
BR (1) BR0308486A (de)
CA (1) CA2479351C (de)
DE (1) DE60327693D1 (de)
ES (1) ES2326471T3 (de)
PT (1) PT1487498E (de)
WO (1) WO2003077952A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8529927B2 (en) 2004-04-30 2013-09-10 Allergan, Inc. Alpha-2 agonist polymeric drug delivery systems
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US20050244463A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
WO2006028361A1 (es) * 2004-09-09 2006-03-16 Arturo Jimenez Bayardo Implantes y microesferas de liberación prolongada de fármacos de uso oftálmico y metodos para prepararlos
US7931909B2 (en) * 2005-05-10 2011-04-26 Allergan, Inc. Ocular therapy using alpha-2 adrenergic receptor compounds having enhanced anterior clearance rates
EP1924292A2 (de) 2005-09-16 2008-05-28 Allergan, Inc. Zusammensetzungen und verfahren zum intraokulären transport therapeutischer arzneimittel
BRPI0718374A2 (pt) * 2006-09-29 2013-06-25 Johnson & Johnson Vision Care mÉtodos e dispositivos oftÁlmicos usados no tratamento de alergias oculares
US20090036404A1 (en) * 2007-08-02 2009-02-05 Macleod Steven K Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
JP5394645B2 (ja) * 2008-03-11 2014-01-22 公益財団法人野口研究所 糖結合型スピロクラウンエーテル誘導体
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9095404B2 (en) 2008-05-12 2015-08-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
AU2009246520B2 (en) 2008-05-12 2012-04-19 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9095506B2 (en) 2008-11-17 2015-08-04 Allergan, Inc. Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
CA2764063C (en) 2009-06-03 2019-05-14 Forsight Labs, Llc Anterior segment drug delivery
JP5775072B2 (ja) * 2009-06-17 2015-09-09 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム 分離剤としてのシクロフルクタン用の組成物および方法
KR20170095402A (ko) 2009-11-09 2017-08-22 알러간, 인코포레이티드 모발 성장을 촉진하기 위한 조성물 및 방법
US20110142889A1 (en) * 2009-12-16 2011-06-16 Nod Pharmaceuticals, Inc. Compositions and methods for oral drug delivery
WO2013040426A2 (en) 2011-09-14 2013-03-21 Forsight Labs, Llc Ocular insert apparatus and methods
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents
CN104884006B (zh) 2012-10-26 2017-12-15 弗赛特影像5股份有限公司 用于持续释放药物到眼睛的眼科系统
CA2901280A1 (en) 2013-02-15 2014-08-21 Allergan, Inc. Sustained drug delivery implant
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
CN106074361B (zh) * 2016-07-14 2018-10-19 何伟 一种抗眼内炎症植入剂及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1491272A (en) * 1975-09-10 1977-11-09 Lingner & Fischer Gmbh Polymer adhesive compositions containing gelling agents
JPH05310805A (ja) * 1992-05-06 1993-11-22 Mitsubishi Kasei Corp アシル化環状イヌロオリゴ糖およびその製造法
JPH06141879A (ja) * 1992-11-05 1994-05-24 Mitsubishi Kasei Corp 環状イヌロオリゴ糖の精製方法
JPH06141856A (ja) * 1992-11-05 1994-05-24 Mitsubishi Kasei Corp 環状イヌロオリゴ糖及び環状イヌロオリゴ糖生成酵素の製造方法
JPH06298807A (ja) * 1993-02-19 1994-10-25 Mitsubishi Kasei Corp 新規な環状イヌロオリゴ糖誘導体
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
JPH0753347A (ja) * 1993-08-19 1995-02-28 Mitsubishi Chem Corp 皮膚化粧料
JPH07274990A (ja) * 1994-04-15 1995-10-24 Mitsubishi Kasei Eng Co 環状イヌロオリゴ糖の精製方法
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
US5980551A (en) * 1997-02-07 1999-11-09 Endovasc Ltd., Inc. Composition and method for making a biodegradable drug delivery stent
US5972363A (en) * 1997-04-11 1999-10-26 Rohm And Haas Company Use of an encapsulated bioactive composition
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
CA2390952C (en) * 2001-07-02 2006-07-11 Rohm And Haas Company Compositions and process for retaining active ingredients comprising networked structured polymers
GB0315745D0 (en) * 2003-07-04 2003-08-13 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
CA2479351A1 (en) 2003-09-25
US20100160437A1 (en) 2010-06-24
WO2003077952A1 (en) 2003-09-25
EP1487498B1 (de) 2009-05-20
CN1642578A (zh) 2005-07-20
JP4523287B2 (ja) 2010-08-11
AU2003214133A1 (en) 2003-09-29
JP2005523299A (ja) 2005-08-04
PT1487498E (pt) 2009-08-19
CA2479351C (en) 2012-05-15
US20060216328A1 (en) 2006-09-28
BR0308486A (pt) 2005-01-18
CN1313155C (zh) 2007-05-02
DE60327693D1 (de) 2009-07-02
EP1487498A1 (de) 2004-12-22
ES2326471T3 (es) 2009-10-13

Similar Documents

Publication Publication Date Title
ATE431749T1 (de) Topische zusammensetzung enthaltend ein cyclofructan, einen träger und einen arzneistoff
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
DK1406633T3 (da) Forbedret lægemiddeltilførsel i transdermale systemer
DE602004004399D1 (de) Grün gefärbte,topische pharmazeutische zusammensetzung auf der basis von metronidazol
ATE445386T1 (de) Polymerische parfümpartikel
DE69928938D1 (de) Neues cyclosporin mit verbesserter wirkung
DK1545662T3 (da) Lægemiddelindgivelsessystem
ATE427763T1 (de) Ballonkatheter
AU2003241469A1 (en) Personal care articles with fragrance delivery system
MXPA06002349A (es) Derivados de aminopropanol.
TW200641091A (en) Organometallic complexes
TW200510344A (en) Aryl-heteroaromatic products, compositions comprising them and use
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
MXPA05008099A (es) Productos n-aril-heteroaromaticos, composiciones que los contienen y su utilizacion.
NO20043646L (no) Osmotisk leveringssystem
MX2007007355A (es) 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor.
TW200631589A (en) Varnish composition based on a solvent of plant origin
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.
PL376130A1 (en) Controlled releases system containing temozolomide
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
EA200300128A1 (ru) Фармацевтические композиции, содержащие карбонат лития
TW200724152A (en) Oligopeptide, derivative thereof, and pharmaceutical composition comprising the same
IS7538A (is) Prógestagena skammta einingar.
PL379424A1 (pl) Nowe układy dostarczania gumy
UA62577C2 (en) Pollentar, pharmaceutical adaptogenic composition

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1487498

Country of ref document: EP